The insertion of an immunodominant H2b-restricted CD8 T-cell epitope from group C adenoviruses allowed us to demonstrate the robust protective potential of these vaccines against influenza and AdV5 infections in C57BL/6J mice. The gene discussed is CD8A; the disease is influenza.